Business Description
GlycoMimetics Inc
NAICS : 325412
SIC : 2834
ISIN : US38000Q1022
Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 83.79 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.02 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.7 | |||||
| 3-Year EPS without NRI Growth Rate | 26.3 | |||||
| 3-Year FCF Growth Rate | 24.4 | |||||
| 3-Year Book Growth Rate | -62.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 88.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.97 | |||||
| 9-Day RSI | 14.84 | |||||
| 14-Day RSI | 23.56 | |||||
| 3-1 Month Momentum % | -2.58 | |||||
| 6-1 Month Momentum % | 5.9 | |||||
| 12-1 Month Momentum % | -6.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.29 | |||||
| Quick Ratio | 2.29 | |||||
| Cash Ratio | 2.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.2 | |||||
| Shareholder Yield % | 0.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -213.55 | |||||
| ROA % | -161.29 | |||||
| ROIC % | -1014.76 | |||||
| 3-Year ROIIC % | -883.44 | |||||
| ROC (Joel Greenblatt) % | -3987.49 | |||||
| ROCE % | -172.31 | |||||
| Moat score | 4 | |||||
| Tariff score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 301.92 | |||||
| Price-to-Tangible-Book | 314 | |||||
| EV-to-EBIT | -42.14 | |||||
| EV-to-EBITDA | -42.17 | |||||
| EV-to-FCF | -39.01 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 314 | |||||
| Price-to-Net-Cash | 314 | |||||
| Earnings Yield (Greenblatt) % | -2.37 | |||||
| FCF Yield % | -2.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLYC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoMimetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -46 | ||
| Beta | 1.73 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 1 | ||
| Volatility % | 157.75 | ||
| 14-Day RSI | 23.56 | ||
| 14-Day ATR ($) | 2.106253 | ||
| 20-Day SMA ($) | 21.142 | ||
| 12-1 Month Momentum % | -6.51 | ||
| 52-Week Range ($) | 14.06 - 63 | ||
| Shares Outstanding (Mil) | 64.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlycoMimetics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlycoMimetics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GlycoMimetics Inc Frequently Asked Questions
What is GlycoMimetics Inc(GLYC)'s stock price today?
The current price of GLYC is $15.70. The 52 week high of GLYC is $63.00 and 52 week low is $14.06.
When is next earnings date of GlycoMimetics Inc(GLYC)?
The next earnings date of GlycoMimetics Inc(GLYC) is 2025-08-08 Est..
Does GlycoMimetics Inc(GLYC) pay dividends? If so, how much?
GlycoMimetics Inc(GLYC) does not pay dividend.
Guru Commentaries on NAS:GLYC
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers